Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy (Q35917802)

11 August 2017

Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy (English)

1 reference

11 August 2017

0 references

1 reference

6

Christophe Hennequin

1 reference

11 August 2017

Pierre Blanchard

1

1 reference

11 August 2017

Laurent Quero

2

1 reference

11 August 2017

Vincent Pacault

3

1 reference

11 August 2017

Marie-Helene Schlageter

4

1 reference

11 August 2017

Valerie Baruch-Hennequin

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

26 March 2012

1 reference

11 August 2017

1 reference

11 August 2017

12

1 reference

11 August 2017

119

1 reference

30 years and a long way into p53 research

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

Epidemiology and pathogenesis of esophageal cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

p53 Antibodies in the sera of patients with various types of cancer: a review

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

11 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-119

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-119

Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-119

P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338390

Perioperative Changes of Serum p53 Antibody Titer is a Predictor for Survival in Patients with Esophageal Squamous Cell Carcinoma

24 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-119

Activation of c-K-ras mutations in human gastrointestinal tumors

21 January 2018

1 reference

12 December 2020

Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma

1 reference

12 December 2020

Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma

1 reference

12 December 2020

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

1 reference

12 December 2020

A note on quantifying follow-up in studies of failure time

1 reference

12 December 2020

p53 antibodies in patients with various types of cancer: assay, identification, and characterization

1 reference

12 December 2020

Serum p53 antibody as a predictor of early recurrence in patients with postoperative esophageal squamous cell carcinoma

1 reference

12 December 2020

Detection of circulating anti-p53 antibodies in esophageal cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-12-119

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

22448886

1 reference